|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.75 AUD | -0.52% |
|
+2.40% | -31.80% |
| 07-01 | ASX Midday Sector Update: Healthcare Stocks Advance, Consumer Staples Sector Struggles | MT |
| 06-29 | Australian shares gain on mining boost and easing US-Iran tensions | RE |
Company Valuation: CSL Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97,314 | 89,299 | 89,052 | 95,184 | 76,024 | 39,093 | - | - |
| Change | - | -8.24% | -0.28% | 6.89% | -20.13% | -48.58% | - | - |
| Enterprise Value (EV) 1 | 101,307 | 88,520 | 99,731 | 105,710 | 85,005 | 47,943 | 47,163 | 46,510 |
| Change | - | -12.62% | 12.66% | 5.99% | -19.59% | -43.6% | -1.63% | -1.39% |
| P/E | 41x | 38.6x | 40.8x | 36.1x | 25.4x | -43.9x | 27.2x | 12.5x |
| PBR | 11.6x | 6.13x | 5.64x | 5.48x | 3.93x | 2.4x | 2.39x | 2.17x |
| PEG | - | -4.91x | -7.25x | 1.8x | 1.9x | 0x | -0x | 0x |
| Capitalization / Revenue | 9.44x | 8.45x | 6.69x | 6.43x | 4.89x | 2.54x | 2.5x | 2.41x |
| EV / Revenue | 9.83x | 8.38x | 7.49x | 7.14x | 5.46x | 3.11x | 3.02x | 2.86x |
| EV / EBITDA | 27.2x | 24.6x | 25.6x | 22.3x | 16.5x | 9.2x | 9.12x | 8.57x |
| EV / EBIT | 32.4x | 30.2x | 32.5x | 27.7x | 19x | 10.7x | 10.6x | 10x |
| EV / FCF | 41.8x | 57.1x | 72.6x | 55.2x | 29.1x | 17.1x | 15.7x | 16.1x |
| FCF Yield | 2.39% | 1.75% | 1.38% | 1.81% | 3.44% | 5.86% | 6.39% | 6.22% |
| Dividend per Share 2 | 2.22 | 2.22 | 2.36 | 2.64 | 2.92 | 2.851 | 2.925 | 3.085 |
| Rate of return | 1.04% | 1.2% | 1.28% | 1.34% | 1.86% | 3.49% | 3.58% | 3.78% |
| EPS 2 | 5.21 | 4.8 | 4.53 | 5.45 | 6.17 | -1.858 | 3.001 | 6.512 |
| Distribution rate | 42.6% | 46.3% | 52.1% | 48.4% | 47.3% | -153% | 97.5% | 47.4% |
| Net sales 1 | 10,310 | 10,562 | 13,310 | 14,800 | 15,558 | 15,392 | 15,635 | 16,244 |
| EBITDA 1 | 3,720 | 3,596 | 3,900 | 4,750 | 5,151 | 5,208 | 5,172 | 5,424 |
| EBIT 1 | 3,130 | 2,927 | 3,069 | 3,812 | 4,468 | 4,464 | 4,447 | 4,652 |
| Net income 1 | 2,375 | 2,255 | 2,194 | 2,642 | 3,002 | -893.6 | 1,183 | 3,112 |
| Net Debt 1 | 3,993 | -778.6 | 10,679 | 10,526 | 8,981 | 8,849 | 8,070 | 7,417 |
| Reference price 2 | 213.82 | 185.38 | 184.61 | 196.96 | 157.01 | 81.63 | 81.63 | 81.63 |
| Nbr of stocks (in thousands) | 455,126 | 481,706 | 482,372 | 483,253 | 484,212 | 478,912 | - | - |
| Announcement Date | 8/17/21 A | 8/16/22 A | 8/14/23 A | 8/12/24 A | 8/18/25 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -43.96x | 3.12x | 9.21x | 3.49% | 39.12B | |
| 16.17x | 3.5x | 9.45x | 0.63% | 63.56B | |
| 27.72x | 5.64x | 16.51x | 0.57% | 55.92B | |
| 34.62x | 11.72x | 22.19x | -.--% | 41.68B | |
| 33.87x | 3.61x | 11.1x | -.--% | 30.97B | |
| -8.4x | 12.02x | -7.38x | -.--% | 28.77B | |
| 16.52x | 3.14x | 9.5x | -.--% | 22.74B | |
| 50.1x | 5.51x | 37.82x | -.--% | 17.64B | |
| 25.89x | 5.38x | 14.42x | -.--% | 16.66B | |
| -34.25x | 15.91x | -48.37x | -.--% | 14.6B | |
| Average | 11.83x | 6.96x | 7.45x | 0.47% | 33.16B | |
| Weighted average by Cap. | 12.96x | 6.32x | 10.13x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CSL Stock
- Valuation CSL Limited
Select your edition
All financial news and data tailored to specific country editions
